Cite
HARVARD Citation
Soulières, D. et al. (n.d.). Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet oncology. 18 (3), pp. 323-335. [Online].